Answers are grounded in this paper and cite their sources.
Randomized trial integrates machine learning with blockchain to enhance data integrity in clinical trials, highlighting necessary biases.
Contemporary clinical trials face major operational challenges. These include high attrition rates, rising costs, and a risk to data integrity and transparency. Many current blockchain models in healthcare do not chain biased data and lack real-time auditing. This shows the need for a better approach to integrating predictive analytics with decentralized security. The framework proposed in this paper combines machine learning (ML) algorithms with a privacy-preserving blockchain platform. This combination aims to improve the safety, transparency, and accuracy of clinical trial outcome predictions and to identify biases in reported trials. This system introduces a majority-voting bias detection mechanism that highlights necessary biases in demographics and reporting before they are recorded permanently. The system architecture relies on Hyperledger Fabric, which provides a decentralized basis for immutable ledger services. Six different ML algorithms were used: Decision Tree, Linear Regression, Logistic Regression, XG-Boost, Random Forest, and Support Vector Machine (SVM). These algorithms predicted trial outcomes and assessed biases based on patient demographics, dosage levels, and study duration. The best-performing model was XG-Boost, achieving the highest accuracy (0.91) and precision (0.90). The results of this research indicate that this hybrid solution leads to a safer, clearer, and ethically sound clinical trial management process. Blockchain, Clinical Trials, Hyperledger Fabric, IPFS, Smart Contracts, Machine Learning, Bias Detection, Data Integrity, ZKP.
No takes yet. Share an insight, caveat, or question.
Shailesh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: